drugset / Trial / NCT00598390

PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

NCT00598390 ↗

Phase 1 Completed 19 enrolled National Institute of Mental Health (NIMH)
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this protocol is to measure brain CB1 receptors in the hope to better understand how they work, so that one day we can understand how the CB1 receptors are involved in psychiatric, neurological, and behavioral disorders.

Timeline

Start
2008-01-08
Primary completion
2013-01-22
Completion
2013-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject [11C]MePPEP Unknown — —

Indications

No indication recorded.